Design, synthesis and biological activity of tetrazole-bearing uric acid transporter 1 inhibitors

Wenqing Cai , Wei Liu , Yafei Xie , Jingwei Wu , Yuqiang Liu , Changying Liu , Weiren Xu , Lida Tang , Jianwu Wang , Guilong Zhao

Chemical Research in Chinese Universities ›› 2017, Vol. 33 ›› Issue (1) : 49 -60.

PDF
Chemical Research in Chinese Universities ›› 2017, Vol. 33 ›› Issue (1) : 49 -60. DOI: 10.1007/s40242-017-6351-3
Article

Design, synthesis and biological activity of tetrazole-bearing uric acid transporter 1 inhibitors

Author information +
History +
PDF

Abstract

Systematic structure-activity relationship(SAR) exploration of a moderately active tetrazole-bearing lesinurad-based hit 1f led to the discovery of a potent uric acid transporter 1(URAT1) inhibitor 1i, which possessed a novel molecular skeleton and was 11-fold more potent than the parent lesinurad against human URAT1 in-vitro (IC50=0.66 μmol/L for 1i vs. 7.18 μmol/L for lesinurad).

Keywords

URAT1 inhibitor / Structure-activity relationship / Drug discovery / Lesinurad / Tetrazole / Bioisostere

Cite this article

Download citation ▾
Wenqing Cai, Wei Liu, Yafei Xie, Jingwei Wu, Yuqiang Liu, Changying Liu, Weiren Xu, Lida Tang, Jianwu Wang, Guilong Zhao. Design, synthesis and biological activity of tetrazole-bearing uric acid transporter 1 inhibitors. Chemical Research in Chinese Universities, 2017, 33(1): 49-60 DOI:10.1007/s40242-017-6351-3

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Richette P., Bardin T. Lancet, 2010, 375(9711): 318.

[2]

Berbal J. A., Quilis N., Andrés M., Sivera F., Pascual E. Ther. Adv. Chronic Dis., 2016, 7(2): 135.

[3]

Punzi L., Scanu A., Ramonda R., Oliviero F. Autoimmun. Rev., 2012, 12(1): 66.

[4]

Zhu Y., Pandya B. J., Choi H. K. Arthritis Rheum., 2011, 63(10): 3136.

[5]

Smith E., Hoy D., Cross M., Merriman T. R., Vos T., Buchbinder R., Woolf A., March L. Ann. Rheum. Dis., 2014, 73(8): 1470.

[6]

Enomoto A., Kimura H., Chairoungdua A., Shigeta Y., Jutabha P., Cha S. H., Hosoyamada M., Takeda M., Sekine T., Igarashi T., Matsuo H., Kikuchi Y., Oda T., Ichida K., Hosoya T., Shimokata K., Niwa T., Kanai Y., Endou H. Nature, 2002, 417(6887): 447.

[7]

Shahid H., Singh J. A. Expert Opin. Investig. Drugs, 2015, 24(8): 1013.

[8]

Hoy S. M. Drugs, 2016, 76(4): 509.

[9]

Ballatore C., Huryn D. M., Smith A. B. Chem. Med. Chem., 2013, 8(3): 385.

[10]

Gottlieb H. E., Kotlyar V., Nudelman A. J. Org. Chem., 1997, 62(21): 7512.

[11]

Zhang X., Wu J., Liu W., Liu Y., Xie Y., Shang Q., Zhou Z., Xu W., Tang L., Wang J., Zhao G., Med. Chem., 10.2174/1573406412666160915163002

[12]

Kennemur J. G., Kilgore C. A., Novak B. M. J. Polym. Sci. Pol. Chem., 2011, 49(3): 719.

[13]

Tian H., Cai W. Q., Xie Y. F., Liu Y. Q., Wei P., Gao Z. G., Tang L. D., Xu W. R., Zhao G. L. Drugs Clinic, 2015, 30(1): 1.

[14]

Spalding D. P., Chapin E. C., Mosher H. S. J. Org. Chem., 1954, 19(3): 357.

[15]

Chawla H. M., Mittal R. S. Synthesis, 1985, 1: 70.

[16]

Pak C. S., Youn I. K., Lee Y. S. Synthesis, 1982, 11: 969.

[17]

Vereshchagin L. I., Petrov A. V., Kizhnyaev V. N., Pokatilov F. A., Smirnov A. I. Rus. J. Org. Chem., 2006, 42(7): 1049.

[18]

Marecki P. E., Weaver J. M. Additives Feed Compositions and Me-thods for Improving Rurninant Feed Utilization, EP0047661, 1982.

[19]

Matthews D. P., Green J. E., Shuker A. J. J. Comb. Chem., 2000, 2(1): 19.

[20]

Kumar A., Sattar M., Verma A., Dara A., Kumar S. RSC Advance, 2015, 5(56): 44728.

[21]

Li Y., Di F., Wang D., Chen W., Wan Y., Li Z. Chem. Res. Chinese Universities, 2015, 31(6): 952.

[22]

Shi F., Fang H., Xu W. Chem. Res. Chinese Universities, 2016, 32(1): 28.

AI Summary AI Mindmap
PDF

137

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/